<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-NAME ACODE="10800">증권발행실적보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20220117">2.6</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00263654">(주)오스코텍</COMPANY-NAME>


<BODY>

<COVER>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">증권발행실적보고서</COVER-TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="430"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" COLSPAN="2" WIDTH="600" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30">금융감독원장 귀하</TD>
<TD CLASS="NORMAL" ALIGN="RIGHT" WIDTH="439" HEIGHT="30">2022년      11월   15일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53">회       사       명 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53">주식회사 오스코텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53">대   표     이   사 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53">김정근, 윤태영</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30">본  점  소  재  지 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">경기도 성남시 분당구 대왕판교로 700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(전  화) 031-628-7666</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(홈페이지) http://www.oscotec.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30">작  성  책  임  자 :</TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(직  책) 전무이사           (성  명) 이상현</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="30"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="30">(전  화) 031-628-7613</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD CLASS="NORMAL" WIDTH="161" HEIGHT="53"></TD>
<TD CLASS="NORMAL" WIDTH="439" HEIGHT="53"></TD>
</TR>
</TBODY>
</TABLE>
</COVER>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-1-0">Ⅰ. 발행개요</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 기업개요</TITLE>

<TABLE-GROUP ACLASS="CRP_OTLN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="613" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업규모</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">업종구분</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TU WIDTH="200" HEIGHT="30" AUNIT="CRP_RGS_CLS" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="2">코스닥</TU>
<TU WIDTH="200" HEIGHT="30" AUNIT="CRP_SCL" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="2">중소기업</TU>
<TU WIDTH="213" HEIGHT="30" AUNIT="CRP_CODE" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="21">의료용 물질 및 의약품 제조업</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 발행 개요</TITLE>

<TABLE-GROUP ACLASS="PBL_OTLN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="609" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="309" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="613" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행총액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TU WIDTH="200" HEIGHT="30" AUNIT="DST_SMR" VALIGN="MIDDLE" ALIGN="CENTER" AUNITVALUE="3">기타</TU>
<TE WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACODE="INC_SL_PO_SUM">88,640,000,000</TE>
<TE WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACODE="NOTE">주주배정 후 실권주 일반공모</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-2-0">Ⅱ. 청약 및 배정에 관한 사항</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 청약 및 납입일정</TITLE>

<TABLE-GROUP ACLASS="SB_DT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약개시일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약종료일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">납입기일</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACODE="SB_CO">구주주(초과청약포함)</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SB_STR_DT" AUNITVALUE="20221107">2022년 11월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SB_END_DT" AUNITVALUE="20221108">2022년 11월 08일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="PYM_DT" AUNITVALUE="20221115">2022년 11월 15일</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 인수기관별 인수금액</TITLE>

<TABLE-GROUP ACLASS="ACC_AMT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수기관</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">인수금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비 율(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비  고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="53" ACODE="ACC_ORG">NH투자증권(주)</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="53" ACODE="ACC_CNT">19,825</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" ACODE="ACC_AMT">274,576,250</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53" ACODE="ACC_RT">0.31</TE>
<TE VALIGN="MIDDLE" WIDTH="106" HEIGHT="53" ACODE="NOTE" ALIGN="CENTER">대표주관회사 단수주 인수</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACODE="TOT_ACC_CNT">19,825</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="TOT_ACC_AMT">274,576,250</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACODE="TOT_ACC_RT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACODE="TOT_NOTE" ALIGN="CENTER">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="76">주1) 초과청약 배정 후 발생한 단수주는 '증권 인수업무 등에 관한 규정' 제9조 제2항 5호에 따라 대표주관회사 NH투자증권(주)가 인수하였습니다. 주2) 비율은 유상증자 신주 수인 6,400,000주를 기준으로 합니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">3. 청약 및 배정현황</TITLE>

<TABLE-GROUP ACLASS="DST_CD" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="923" BORDER="0">

<COLGROUP>
<COL WIDTH="420"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="429" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" WIDTH="494" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="1">(단위 : 원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="924" BORDER="1">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초 배정</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="316" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">청약 현황</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="316" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최종 배정 현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">건수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">건수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="DST_CD">신주인수권증서청약</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">6,400,000</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="FST_DV_RT">100.0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">15,143</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SB_ST_CNT">5,742,730</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SB_AMT">79,536,810,500</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SB_RT">90.0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">15,143</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">5,742,730</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">79,536,810,500</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="DV_RT">89.7</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="DST_CD">초과청약</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="FST_DV_RT">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">10,991</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SB_ST_CNT">637,445</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SB_AMT">8,828,613,250</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SB_RT">10.0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">10,991</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">637,445</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">8,828,613,250</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="DV_RT">10.0</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="DST_CD">단수주</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="FST_DV_RT">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SB_ST_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SB_AMT">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SB_RT">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT">1</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT">19,825</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT">274,576,250</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="DV_RT">0.3</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="FST_DV_CNT_TOT">6,400,000</TE>
<TD ALIGN="RIGHT" WIDTH="55" HEIGHT="30" AUPDATECONT="N">100</TD>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SB_CNT_TOT">26,134</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SB_ST_CNT_TOT">6,380,175</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="SB_AMT_TOT">88,365,423,750</TE>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" AUPDATECONT="N">100</TD>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="DV_CNT_TOT">26,135</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="DV_ST_CNT_TOT">6,400,000</TE>
<TE ALIGN="RIGHT" WIDTH="121" HEIGHT="30" ACODE="DV_AMT_TOT">88,640,000,000</TE>
<TD ALIGN="RIGHT" WIDTH="48" HEIGHT="30" AUPDATECONT="N">100</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">4. 일반투자자 배정방식별 배정현황</TITLE>

<TABLE-GROUP ACLASS="NOR_ASS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">배정수량(주)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">균등방식 유형</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">균등방식</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_RT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="EQV_TYP">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">비례방식</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="PRP_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="PRP_RT">-</TE>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="CNT_TOT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="RT_TOT">-</TE>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">5. 기관투자자 의무보유확약기간별 배정현황</TITLE>

<TABLE-GROUP ACLASS="INS_ASS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="804" BORDER="0">

<COLGROUP>
<COL WIDTH="393"></COL>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="402" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="402" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="804" BORDER="1">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="42"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">확약기간</TH>
<TH COLSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="410" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">국내 기관투자자</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="204" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">외국 기관투자자</TH>
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용사(집합)</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">투자매매ㆍ중개업자</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">연기금,운용사(고유)은행,보험</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기타</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">거래실적유</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">거래실적무</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비중</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="ASS_PRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_RT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" ACODE="ASS_PRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="IN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="IN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="EX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TOT_RT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" AUPDATECONT="N">미확약</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="NIN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="NIN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NIN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NEX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NTOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="NTOT_RT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="TIN_MNG_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACODE="TIN_MNG_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BRK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BRK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BNK_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_BNK_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TIN_ETC_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRY_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRY_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRN_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TEX_TRN_RT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TTOT_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="51" HEIGHT="30" ACODE="TTOT_RT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-3-0">Ⅲ. 유상증자 전후의 주요주주 지분변동</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="81"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ROWSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증자 전</TH>
<TH COLSPAN="2" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증자 후</TH>
<TH ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주식수</TH>
<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">지분율</TH>
<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주식수</TH>
<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">김정근</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">4,516,710</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">14.34%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">4,763,955</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12.57%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">대표이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">김세원</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">비등기임원</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">307,766</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.98%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">347,766</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.92%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">박상기</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">친인척</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">68,860</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.22%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">82,854</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.22%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">최성애</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">친인척</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,345</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.00%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,345</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.00%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">이상현</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">등기임원</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">48,162</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.15%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">57,949</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.15%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">서은호</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">비등기임원</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">2,200</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.01%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">2,700</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.01%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">윤태영</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">등기임원</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">3,503</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.01%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">4,214</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.01%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">대표이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">김윤태</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">미등기임원</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,600</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.01%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,600</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">0.00%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="156" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">4,950,146</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">15.72%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">5,262,383</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">13.89%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="156" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">발행주식 총수</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">31,492,063</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">100.00%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">37,892,063</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">100.00%</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="610" HEIGHT="99">주1) 증자 전은 본 유상증자의 신주배정기준일인 2022년 09월 28일 기준이며, 증자 후는 납입일 익일 기준 입니다.주2) 유상증자 이후 지분율은 유상증자 전 발행주식총수인 31,492,063주에 본건 유상증자 신주 수인 6,400,000주를 더한 37,892,063주를 기준으로 합니다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X0000FF B"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-4-0">Ⅳ. 증권교부일 등</TITLE>
<P></P>
<P>- 증자 등기 신청 예정일 : 2022년 11월 16일</P>
<P>- 주권상장 및 유통 개시 예정일 : 2022년 11월 30일</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-5-0">Ⅴ. 공시 이행상황</TITLE>

<P>
<SPAN USERMARK=" B">1. 공고의 일자 및 방법</SPAN>
</P>

<TABLE BORDER="1" WIDTH="642" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="222"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="249"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구 분</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">공고일자</TH>
<TH WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">공고방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신주 발행 및배정기준일(주주확정일) 공고</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022년 08월 26일</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사 인터넷 홈페이지(http://www.oscotec.com)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">모집가액 확정의 공고</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2022년 11월 03일</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">전자공시시스템(http://dart.fss.or.kr)회사 인터넷 홈페이지(http://www.oscotec.com)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">2. 증권신고서</SPAN>가. 전자문서 : 금융위(금감원) 전자공시시스템 →  http://dart.fss.or.kr나. 증권신고서 제출일 : [증권신고서 제출 및 정정 연혁]  
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="274"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제출일자</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">문서명</TH>
<TH WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 08월 26일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 07일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정(굵은 파란색)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 13일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정(굵은 빨간색)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 14일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[기재정정]증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정(굵은 녹색)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 26일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[발행조건확정]증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정(굵은 하늘색)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 11월 03일</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[발행조건확정]증권신고서(지분증권)</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기재정정(굵은 주황색)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">3. 투자설명서</SPAN>가. 전자문서 : 금융위(금감원) 전자공시시스템 →  http://www.oscotec.com나. 서면문서 : (주)오스코텍 →  경기도 성남시 분당구 대왕판교로 700                      NH투자증권(주) → 서울특별시 영등포구 여의대로 108[투자설명서 제출 및 정정 연혁]
</P>

<TABLE BORDER="1" WIDTH="693" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="210"></COL>
<COL WIDTH="318"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제출일자</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">문서명</TH>
<TH WIDTH="327" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 09월 28일</TD>
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">투자설명서</TD>
<TD WIDTH="327" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초 제출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022년 11월 03일</TD>
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[발행조건확정] 투자설명서 </TD>
<TD WIDTH="327" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최종 발행가액 확정에 따른 정정(파란색)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-6-0">Ⅵ. 조달된 자금의 사용내역</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 자금조달 내용</TITLE>

<TABLE-GROUP ACLASS="INC_SL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="709" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="392"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="401" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="711" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식구분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">신고서상발행예정총액</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="367" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">실제 조달금액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">발행가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">수 량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">발행총액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" AUPDATECONT="N">모집</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_RPT_MN">88,640,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_STK_AMT">13,850</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_STK_CNT">6,400,000</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_STK_TOT">88,640,000,000</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="INC_NOTE" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_RPT_TOT">88,640,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_AMT_TOT">13,850</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_CNT_TOT">6,400,000</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_TOT">88,640,000,000</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="INC_NOTE_TOT" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" AUPDATECONT="N">매출</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SL_STK_KND">-</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_RPT_MN">-</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_STK_AMT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_STK_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_STK_TOT">-</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="SL_NOTE" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SL_STK_KND">-</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_RPT_MN">-</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_STK_AMT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_STK_CNT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_STK_TOT">-</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="SL_NOTE" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_RPT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="SL_AMT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_CNT_TOT">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="SL_TOT">-</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="SL_NOTE_TOT" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" AUPDATECONT="N">총  계</TD>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_SL_RPT_SUM">88,640,000,000</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="30" ACODE="INC_SL_AMT_SUM">13,850</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_SL_CNT_SUM">6,400,000</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="INC_SL_SUM">88,640,000,000</TE>
<TE WIDTH="110" HEIGHT="30" ACODE="TOT_NOTE" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 자금의 사용목적</TITLE>

<TABLE-GROUP ACLASS="INC_PRPS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="616" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="307"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="316" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="660" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">시설자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">영업양수자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">운영자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">채무상환자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">타법인증권취득자금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기타</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="121" HEIGHT="30" ACODE="FND_USE1" VALIGN="MIDDLE" ALIGN="RIGHT">4,500,000,000</TE>
<TE WIDTH="78" HEIGHT="30" ACODE="FND_USE_SQ" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="121" HEIGHT="30" ACODE="FND_USE2" VALIGN="MIDDLE" ALIGN="RIGHT">84,140,000,000</TE>
<TE WIDTH="78" HEIGHT="30" ACODE="FND_USE5" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="93" HEIGHT="30" ACODE="FND_USE_AS" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="48" HEIGHT="30" ACODE="FND_USE4" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="121" HEIGHT="30" ACODE="FND_USE_SUM" VALIGN="MIDDLE" ALIGN="RIGHT">88,640,000,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>당사는 금번 유상증자를 통하여 조달 예정인 약 226억원을 시설자금으로 사용할 계획입니다. </P>

<P>
<SPAN USERMARK=" 0X141414">당사는 금번 유상증자를 통하여 모집되는 자금 중 84,140백만원을 연구개발 등을 위한 운영자금으로 사용할 계획입니다. 당사의 진행중인 파이프라인[SKI-O-703(13,600백만원), SKI-G-801(14,500백만원),  ADEL-Y01(17,640백만원), LSD-1(6,700백만원), EP2/4(8,000백만원)]에 총 60,440백만원을 사용할 예정이며, 이외에 신규 파이프라인 개발에 15,000백만원, 직원급여에 7,600백만원을 사용할 계획입니다. 개발에 사용되는 자금은 회계상 연구개발비로 처리될 예정입니다. 그리고 본건 유상증자를 통하여 연구개발비(84,140백만원) 및 시설장비 구입 비용(4,500백만원)을 합한 금액인 87,540백만원을 초과하여 자금조달이 이루어진 경우에는 해당 금액을 감사수수료 및 외부평가 비용, 유상증자 수수료 등에 1,100백만원을 사용할 계획입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1288" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1279"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1288" HEIGHT="30">[유상증자 자금사용의 우선순위]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1288" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1290">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">우선순위</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">구분</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">자금용도</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">22년 4분기</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">23년 1분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">23년 2분기</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">23년 3분기</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">23년 4분기</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">24년 1분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">24년 2분기</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">24년 3분기</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">24년 4분기</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">1</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">운영자금</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">연구개발비</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">9,200</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">13,000</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,450</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">8,200</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">9,100</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,740</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12,350</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30" USERMARK=" 0X141414">83,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">2</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">시설자금</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">연구장비</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="100" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="100" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30" USERMARK=" 0X141414">4,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">3</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">운영자금</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">증자수수료 등</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,100</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="100" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="100" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30" USERMARK=" 0X141414">1,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="269" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X141414">합계</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,100</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,700</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">13,000</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">11,500</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,450</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">8,200</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">9,100</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12,240</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12,350</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="95" HEIGHT="30" USERMARK=" 0X141414">88,640</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="1288" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1279"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1288" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>

<TABLE ACLASS="NORMAL" WIDTH="1491" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1482"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1491" HEIGHT="30">[유상증자 자금의 세부사용내역]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="1491" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1488">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">자금용도</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">세부내용</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">22년 4분기</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">23년 1분기</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">23년 2분기</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">23년 3분기</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">23년 4분기</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">24년 1분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">24년 2분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">24년 3분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">24년 4분기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="10" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="323">운영자금</TD>
<TD ROWSPAN="9" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="270">연구개발비</TD>
<TD ROWSPAN="5" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">임상개발비 등</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">SKI-O-703</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">350</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,250</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,250</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">13,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">SKI-G-801</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">1,250</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">14,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">ADEL-Y01</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">2,640</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">3,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">17,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">LSD1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">200</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">4,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">400</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">400</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">400</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">400</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">400</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">6,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">EP-2/4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">2,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">8,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">신규파이프라인 개발</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">진행중 Drug Discovery</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">5,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신규과제 도입 및 개발</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">550</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">550</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">550</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">550</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">800</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">3,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">플랫폼개발</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">6,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">직원 급여</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구원 급여</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">750</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,150</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,150</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,150</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,150</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">7,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" COLSPAN="2">수수료 지급</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">감사수수료 및 외부평가 비용,유상증자 수수료 등</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">1,100</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="53" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="53" USERMARK=" 0X141414">1,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3">시설자금</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ROWSPAN="3" COLSPAN="2">연구장비 등 구입</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">FACS, SPR 등</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구공간 리노베이션</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">형광현미경 등</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="99" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="502" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,100</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,700</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">13,000</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">11,500</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">10,450</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">8,200</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">9,100</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12,240</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">12,350</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30" USERMARK=" 0X141414">88,640</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="1288" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1279"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1288" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 운영자금</SPAN>▶ 연구개발비(임상시험비용 등)1) SKI-O-703당사가 개발 중인 SKI-O-703은 SYK Inhibitor로 자가면역질환을 타겟으로 하는 신약물질입니다. SYK(Spleen Tyrosine Kinase)란 자가면역질환(류마티스 관절염, 면역성 혈소판감소증, 염증 질환 등)을 일으키는 주된 단백질 중 하나로 당사는 SYK 저해제에 적용되는 신약물질을 개발 중에 있습니다. 자가면역질환이란 면역시스템이 자신을 공격하여 발생하는 질환을 뜻합니다. 개발 초기 당사는 자가면역질환 중 대표적인 질환인 류마티스 관절염(RA, Rheumatoid Arthritis)을 적응증으로 하여 임상을 진행했으나, 현재 당사는 수많은 자가면역질환 중 SYK의 역할이 중요할 것으로 보이는 질환을 선정하여 동시다발적인 임상개발을 적극적으로 추진하여, 면역성 혈소판 감소증(ITP, Immune Thrombocytopenia) 적응증을 대상으로 치료제 연구개발 목적으로 임상2상 진행 중에 있습니다. 당사는 SKI-O-703의 임상시료 생산 관련하여 3,000백만원을 사용할 계획이며, 현재 진행 중인 ITP 적응증 대상 임상2상 진행에 따른 비용 
<SPAN USERMARK=" 0X141414">8,000백만원</SPAN>과 이후 동 적응증을 대상으로 임상3상 진입에 들어가기 위한 준비 시험 단계에 
<SPAN USERMARK=" 0X141414">2,600백만원</SPAN>을 사용할 계획입니다. 이러한 계획을 바탕으로 당사는 추후 다양한 자가면역질환 적응증을 대상으로 확대해 나갈 계획입니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="940">

<COLGROUP>
<COL WIDTH="931"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30">[SKI-O-703 관련 세부지출 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="940" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="255"></COL>
<COL WIDTH="225"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제</TH>
<TH WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">SKI-O-703</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상시료 생산 관련 비용</TD>
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10억/Trial (Trial 3회 가정)</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">면역성 혈소판 감소증(ITP) 치료제 개발</TD>
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">ITP Global 2상 완료에 따른 비용 정산</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 2분기 ~ 3분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">8,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">ITP Global 3상 진입전 준비실험</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 4분기 ~ 2024년 4분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">2,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">신규 적응증 임상 시험</TD>
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상 진입</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 2분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중개 연구용역 비용</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기 ~ 3분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="801" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">13,600</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>

<P>2) SKI-G-801당사의 SKI-G-801은 AXL/FLT3 이중 저해제로 현재 급성골수성 백혈병(AML, Acute Myeloid Leukemia) 및 고형암 환자를 대상으로 임상 진행 중에 있습니다. 2022년 4월 1일 AML 환자 대상 1상(OSCO-P1301) 데이터를 발표하였으며, 해당 약물이 Target하는 일부 환자에게서 완전 관해(CR, Complete Response) 사례를 확인하였습니다. 당사는 SKI-G-801에 대하여 AML 적응증 대상으로 임상2상 진입 준비 중에 있으며, 이와 관련하여 6,000백만원을 사용할 계획입니다. 더불어, 당사는 AML 임상1상시험 결과 데이터를 바탕으로, 난치성 고형암에 대한 적응증 확대로 임상1상 진행 중에 있습니다. 당사는 고형암 환자를 대상으로 하는 임상1상시험 관련하여 2,000백만원, 임상시험 내 다양한 집단을 대상으로 임상시험 진행을 위한 Cohort Expansion 진행 관련 2,000백만원, 추후 임상2상 진입을 위한 비용 
<SPAN USERMARK=" 0X141414">1,500백만원을 사용할 계획</SPAN>입니다. 이외의 당사가 SKI-G-801 관련하여 임상시료 생산 관련 비용 3,000백만원을 사용할 예정입니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="940">

<COLGROUP>
<COL WIDTH="931"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30">[SKI-G-801 관련 세부지출 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="940" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="240"></COL>
<COL WIDTH="240"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제</TH>
<TH WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">SKI-G-801</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상시료 생산 관련 비용</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10억/Trial (Trial 3회 가정)</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 1분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">급성골수성 백혈병치료제</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상 2상 진입</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 1분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">고형암 치료제 개발 </TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내 임상1상 진행</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Cohort Expansion 진행</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기 ~ 3분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상 2상 진입</TD>
<TD WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 4분기 ~ 2024년 4분기</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="801" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">14,500</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>

<P>3) ADEL-Y01당사는 TKI 위주의 저분자 화합물 신약뿐만이 아니라 바이오신약의 영역으로 역량을 확장하기 위해 2020년 퇴행성뇌질환 치료제 개발을 위해 주식회사 아델과 신약물질 기술도입 및 공동연구 계약을 체결하였습니다. 당사는 동 계약을 통해 퇴행성뇌질환을 발병시키는 Tau에 대한 항체 ADEL-Y01에 대하여 전임상 및 임상개발, 특허출원, 등록 및 관리, 허가 및 상업화 권리를 부여하는 것과 관련하여 계약서 내의 규정된 권리 의무를 수행하여야 하며 계약 기간은 계약체결일로부터 계약제품의 제품출시일로부터 10년 또는 계약기술의 유효청구항의 최종 소멸일 중 늦은 날입니다. 해당 약물은 Tau를 타겟으로 하는 단클론항체 신약으로, Tau는 신경세포의 세포체에서 길에 뻗어나온 가지인 축삭을 이루는 미세소관 필라멘트의 핵심 구성요소 단백질로, 현재 알츠하이머 진단의 중요한 바이오마커로 활용되고 있는 물질입니다.ADEL-Y01은 현재 전임상을 마치고 GLP-Tox(24주 독성) Test를 진행 중에 있으며, IND 제출 및 1상 진입을 목표로 하고 있습니다. 당사는 이를 위해 임상1상 진입을 위해 6,000백만원, 임상1상 진행 시 필요한 환자 모집, Site 추가 및 바이오커 분석 비용 관련하여 
<SPAN USERMARK=" 0X141414">3,640백만원</SPAN>을 사용할 계획입니다. 추가로, ADEL-Y01 관련하여 임상시료 생산 관련 비용 3,000백만원을 사용할 예정입니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="940">

<COLGROUP>
<COL WIDTH="931"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30">[ADEL-Y01 관련 세부지출 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="940" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="303"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제</TH>
<TH WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">ADEL-Y01</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상시료 생산 관련 비용</TD>
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10억/Trial (Trial 3회 가정)</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">퇴행성뇌질환</TD>
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상1상 진입</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상1상 진행 시 환자 모집 비용</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 2분기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XFF1200 B">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Global 임상1상 진행 시 바이오커 분석 비용</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기 ~ 2024년 4분기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">3,640</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="833" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">17,640</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>

<P>4) LSD-1 및 EP2/4당사는 2021년 3월 스웨덴의 바이오텍 비악티카(Beactica Therapeutics AB)와 공동연구개발 계약을 체결을 통해 면역항암제로 개발 중인 LSD1 관련하여 초기 전임상 연구를 공동으로 진행하기로 하였습니다. 동 계약체결로 인해 당사는 Beactica에 지분투자 및 총 1억 4,900만유로(약 2,000억원) 규모의 마일스톤ㆍ라이센스 수익 분배 등을 지급하기로 하였습니다. LSD1은 이중기능을 가진 후성유전 단백질로, 질병과 관련된 단백질 발현을 조절합니다. 특히, LSD1을 조절하는 것은 암을 치료하고 면역체계를 높일 수 있는 효과가 있으며 비악티카는 LSD1 저해제 개발을 통해 전임상에서 교모세포증을 포함한 여러 암모델에서 항암 효능을 확인하였다고 밝혔습니다. 이에 따라 당사는 비악티카와 함께 LSD1 저해제 개발을 통해 안정성과 적응증을 갖춘 치료제로의 개발을 위해 노력하고 있습니다. 더불어, 당사는 2022년 3월 신규면역항암치료제 개발을 목적으로 주식회사 카나프테라퓨틱스와 신약물질인 EP-2/4기술도입 및 공동연구 계약을 체결하였으며, 임상진입에 따른 마일스톤 지급 및 해당 물질을 적용한 치료제의 매출 발생 시 경상기술료 지급 등의 계약조건이 포함되어 있습니다. EP-2/4는 새로운 기전의 항암제로 개발될 가능성이 높으며, 세계적으로 아직 개발 초기 단계인 상태입니다. 당사는 후보물질에 대한 전임상 시험을 카나프테라퓨틱스와 공동으로 진행하며 향후 임상 진입을 목표로 세웠습니다. 당사의 후보물질은 2개 이상의 암 관여 물질을 억제하는 면역 항암제로 암세포의 악성화 과정에서 분화, 내성, 전이, 면역억제 환경조성 등을 유도하는 수용체를 동시에 억제 가능하도록 개발하고 있습니다.당사는 LSD1 저해제 관련하여 비악티카와 공동연구 개발에 따른 License Fee 지급 관련 비용 
<SPAN USERMARK=" 0X141414">6,700백만원</SPAN>에 사용할 예정이며, EP-2/4 관련 치료제에 대하여 카나프테라퓨틱스와의 공동연구 개발에 따른 마일스톤 비용 
<SPAN USERMARK=" 0X141414">8,000백만원</SPAN>에 사용할 계획입니다. 
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1029">

<COLGROUP>
<COL WIDTH="1020"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1029" HEIGHT="30">[LSD-1 및 EP-2/4 관련 세부지출 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1029" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1031" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="303"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제</TH>
<TH WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급 대상</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">LSD-1 저해제</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">면역항암제 개발</TD>
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동연구 개발에 따른 License Fee 지급</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Beactica</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 2분기</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">6,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">EP-2/4</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">면역항암제 개발</TD>
<TD WIDTH="312" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공동연구 개발에 따른 마일스톤 지급</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">카나프테라퓨틱스</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 4분기</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">8,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="916" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">14,700</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P>▶ 신규 파이프라인</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1029">

<COLGROUP>
<COL WIDTH="1020"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1029" HEIGHT="30">[신규 파이프라인 개발 계획]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1029" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1027" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="492"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="501" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Drug Discovery</TD>
<TD WIDTH="501" VALIGN="MIDDLE" HEIGHT="30">전임상전 신약 후보물질 License-In 또는 공동연구 개발</TD>
<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기 ~ 2024년 4분기</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">5,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신규과제</TD>
<TD WIDTH="501" VALIGN="MIDDLE" HEIGHT="30">신약물질을 개발하여 치료제에 쓰일 수 있는 연구ㆍ개발 계획</TD>
<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 4분기 ~ 2024년 4분기</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">3,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">플랫폼 개발</TD>
<TD WIDTH="501" VALIGN="MIDDLE" HEIGHT="30">신규 Target 및 물질의 지속적 발굴을 위한 당사 고유 Platform 구축</TD>
<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2023년 1분기 ~ 2024년 4분기</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">6,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="841" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X141414">15,000</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="687" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="678"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="687" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">2. 시설자금</SPAN>당사는 금번 유상증자를 통하여 모집되는 자금 중 
<SPAN USERMARK=" 0X141414">4,500백만원</SPAN>을 연구장비 구입 등을 위한 시설자금으로 사용할 계획입니다. 당사는 본건 유상증자를 통해 조달한 자금 중 일부를 노후화된 실험장비 교체 및 신규 연구기자재 구입과 연구공간 리노베이션 등에 사용할 계획입니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="858" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="849"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="858" HEIGHT="30">[시설자금의 세부 사용내역]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="858" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="857">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="224"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구장비</TH>
<TH WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구입 목적</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구매 대금</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구입시기 예정</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">FACS, SPR 등</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="233" HEIGHT="30">기존장비 노후화에 따른 교체</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="208" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="208" HEIGHT="30">2023년 1분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구공간 리노베이션</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="233" HEIGHT="30">신규과제 및 연구실 확충</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="208" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="208" HEIGHT="30">2023년 3분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">형광현미경 등</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="233" HEIGHT="30">과제 진척에 따른 신규장비 도입</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="208" HEIGHT="30" USERMARK=" 0X141414">1,500</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="208" HEIGHT="30">2024년 3분기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="441" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="208" HEIGHT="30" USERMARK=" 0X141414">4,500</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="208" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">자료 : 당사 제시</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>3) 기타사항당사가 금번 유상증자를 통해 조달한 자금 중 일부 자금은 조달시기와 사용시기가 다소 차이가 있을 수 있습니다. 사용시기까지의 조달금액은 국내 제 1금융권 및 증권사 등 안정성이 높은 금융기관의 상품에 예치할 계획이며, 또한, 당사의 연구개발을 위한 연구장비의 투자 금액 중 금번 공모를 통해 조달한 금액 외에 부족한 자금은 당사가 보유한 현금및현금성자산 및 은행 차입 등을 통해 조달할 예정입니다. 투자시 참고 하시기 바랍니다.</P>
<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-7-0">Ⅶ. 신주인수권증서 발행내역</TITLE>
<P></P>

<LIBRARY>
<TABLE-GROUP ACLASS="SUBR_PUB" ADELETETABLE="N">
<TITLE ATOC="N">신주인수권증서 발행내역</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="283"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="292" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청구일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행시기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청구자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행회사와의 관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" AUNIT="DMND_DT" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACODE="PUB_PRD">2022년 10월 13일</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" ACODE="DMNDER">KB국민은행 증권대행부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ACODE="RLT">명의개서 대행기관</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACODE="ST_CNT">6,386,115</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="519" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACODE="ST_TOT">6,386,115</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUBR_SUB" ADELETETABLE="N">
<TITLE ATOC="N">신주인수권증서에 의한 청약내역</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="283"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="308" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="292" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청약일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">청약자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행회사와의 관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SUB_DT" AUNITVALUE="20221108">2022년 11월 08일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="53" ACODE="SBER">한국예탁결제원(신주인수권증서 청약)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACODE="ST_CNT">5,742,160</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SUB_DT" AUNITVALUE="20221108">2022년 11월 08일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="53" ACODE="SBER">한국예탁결제원(초과청약)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACODE="ST_CNT">637,445</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" AUNIT="SUB_DT" AUNITVALUE="20221108">2022년 11월 08일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="184" HEIGHT="53" ACODE="SBER">직접청약(신주인수권증서 청약)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" ACODE="RLT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACODE="ST_CNT">570</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="450" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="ST_TOT">6,380,175</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-0-8-0">Ⅷ. 실권주 처리내역</TITLE>
<P></P>
<P USERMARK=" B">1. 신주인수권증서 청약 실권주 및 단수주</P>

<TABLE WIDTH="618" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30"></TD>
<TD WIDTH="310" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>신주인수권증서 청약 실권주</P>
</TH>

<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구주주 배정 단수주</P>
</TH>

<TH WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>실권주 및 단수주 총계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">643,385</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,885</TD>
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">657,270</TD>
</TR>
</TBODY>
</TABLE>

<P>주) 구주주 배정 단수주 : 구주주 최초배정주식수 6,400,000주에서 구주주들에게 실제로 배정되어 발행된 신주인수권증서의 합인 6,386,115주를 차감한 단수주
<SPAN USERMARK=" B">2. 신주인수권증서 청약 실권주 및 단수주 처리 내역 : 초과청약 배정</SPAN>
</P>

<TABLE WIDTH="629" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="312"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30"></TD>
<TD WIDTH="321" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="225"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>신주인수권증서 청약실권주 및 단수주</P>
</TH>

<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>초과청약주식수</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>초과청약배정비율</P>
</TH>

<TH WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">657,270</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">637,445</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.0</TD>
<TD WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">초과청약 단수주 19,825주 발행</TD>
</TR>
</TBODY>
</TABLE>
<P>주) 초과청약으로 발생한 단수주(19,825주)는 대표주관회사인 NH투자증권(주)이 인수함.</P>
<P></P>
</SECTION-2>
</LIBRARY>

</SECTION-1>
</BODY>
</DOCUMENT>